Research And Development
Shaping the future of noninvasive diagnostics with artificial intelligence.
Strong Scientific Expertise
Widely used, researched and validated patented test
![](https://fibronostics.com/wp-content/uploads/2023/07/pexels-lukas-590022-scaled-1-1024x678.jpg)
Evaluating serum biomarkers LiverFast surrogates of liver fibrosis and steatosis could identify risks in a clinical population experiencing sars-cov2 infection (COVID).
Lead Author
Dr. Maryna Raskin
Study Population
Miscellaneous n=10,623
LIVERFASt™ & LIVERFASt Select
Conclusion
LIVERFASt™ Steatosis and Fibrosis scores are NITs that could be used to screen populations at risk of MetS and liver disease to identify those at risk of COVID-19.
Location
Health Catalyst US
![](https://fibronostics.com/wp-content/uploads/2023/07/usflag.png)
Lead Author
Dr. Brian Cohn
Study Population
IT simulations
10,000 replicates per biomarker
Conclusion
Noise injection allows for nuanced tailoring & interpretation of results inferred by an AIA. We equip clinicians with an interactive tool to contextualize therapeutic expectations & aid in patient education towards adherence endpoints. In effect, providing a new, nuanced view of how AIA assess LD.
Location
Fibronostics US
![](https://fibronostics.com/wp-content/uploads/2023/07/usflag.png)
Lead Author
Abhishek Aravind
Study Population
NAFL to advanced NASH n=2862
LIVERFASt™
Conclusion
The modified SAF scoring system generated by LIVERFASt™ provided a simple & convenient diagnosis of NAFLD & NASH, and staging of the three liver lesions as shown in a cohort of SEA.
Location
Fibronostics Singapore
![](https://fibronostics.com/wp-content/uploads/2022/10/images.png)
Lead Author
Prof. Lim Seng Gee
Study Population
CHB n=724, LIVERFASt™
Conclusion
LF-Fibrosis & LF-Activity are reliable tools for screening HBV infected patients & for detecting phase-related liver disease, with better NPV than APRI or FIB-4. Management of HBV pts could be improved by LF tests.
Location
National University Health System (NUHS) Singapore
![](https://fibronostics.com/wp-content/uploads/2022/10/images.png)